Patients beginning therapy on popular osteoporosis drugs discontinue treatment within 6 months: Report
Links shared publicly online about this topic.
- 1,095total visits
Patients beginning therapy on popular osteoporosis drugs discontinue treatment within 6 months: Report
According to a recent analysis by SDI, a leading healthcare market insight and analytics firm, about half of patients beginning therapy on popular osteoporosis drugs discontinue their treatment within 6 months. Amgen's Prolia, which was recently approved for postmenopausal women with osteoporosis at high risk of fracture, or patients who could not tolerate other osteoporosis therapies, is the newest product to enter the market. Prolia differs from existing therapies as it is given every 6 months
View full resource at news-medical.net
Tags: Fracture, Osteoporosis, Osteoporosis Medication, Drug, Healthcare, Women's Health, Prolia, Amgen
Most Recently Shared on June 14, 2010 at 1:12 pm By:
Osteoporosis News: Patients beginning therapy on popular osteoporosis drugs discontinue treatment within 6 months:... http://bit.ly/aUwQpN
SDI Reports: Approximately Half Of Patients Prescribed The Most Popular Osteoporosis Drugs Discontinue Therapy Within 6 Months
medicalnewstoday.com — “According to a recent analysis by SDI, a leading healthcare market insight and analytics firm, about half of patients beginning therapy on popular osteoporosis drugs discontinue their treatment wi” View full resource at medicalnewstoday.com
Most Recently Shared on June 16, 2010 at 1:07 pm By:
MNT Bones/Orthopedic Health News
SDI Reports: Approximately Half Of Patients Prescribed The Most Popular Osteoporosis Drugs Discontinue Therapy Within ... http://mnt.to/3DVz
Advertisement
